advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (24)
Showing records 1 to 24
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation54431 Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity
Lee SY; Wong TT; Chua J; Boo C; Soh YF; Tong L
Eye 2013; 27: 1142-1150
54695 In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma
Frezzotti P; Fogagnolo P; Haka G; Motolese I; Iester M; Bagaglia SA; Mittica P; Menicacci C; Rossetti L; Motolese E
Acta Ophthalmologica 2014; 92: e133-e140
54451 Scanning electron microscopy applied to impression cytology for conjunctival damage from glaucoma therapy
Cennamo G; Forte R; Del Prete S; Cardone D
Cornea 2013; 32: 1227-1231
54564 Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes
Shafiee A; Bowman LM; Hou E; Hosseini K
Clinical Ophthalmology 2013; 7: 1549-1556
54488 Relative Efficacy and Safety of Preservative-free Latanoprost (T2345) for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: An Adjusted Indirect Comparison Meta-Analysis of Randomized Clinical Trials
Cucherat M; Stalmans I; Rouland JF
Journal of Glaucoma 2014; 23: e69-e75
54858 Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial
Russ HH; Nogueira-Filho PA; Barros Jde N; Faria NV; Montiani-Ferreira F; Gomes JÁ,; Mello PA
Clinics 2013; 68: 1318-1324
54664 Investigation on novel chitosan nanoparticle-aptamer complexes targeting TGF-β receptor II
Chen X; Zhu X; Li L; Xian G; Wang W; Ma D; Xie L
International Journal of Pharmaceutics 2013; 456: 499-507
54844 The effects of ocular hypotensive drugs on the cornea: an in vivo analysis with confocal microscopy
Ferná,ndez Jimé,nez-Ortiz H; Toledano Ferná,ndez N; Ferná,ndez Escamez CS; Perucho Martinez S; Crespo Carballé,s MJ
Archivos de la Sociedad Espaņola de Oftalmologia 2013; 88: 423-432
54769 Critical Assessment of Implantable Drug Delivery Devices in Glaucoma Management
Manickavasagam D; Oyewumi MO
Journal of Drug Delivery 2013; 2013: 895013
54528 Novel bioadhesive hyaluronan-itaconic acid crosslinked films for ocular therapy
Calles JA; Tá,rtara LI; Lopez-Garcí,a A; Diebold Y; Palma SD; Vallé,s EM
International Journal of Pharmaceutics 2013; 455: 48-56
54735 Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide
Verma P; Gupta RN; Jha AK; Pandey R
Drug Delivery 2013; 20: 269-276
54573 Effect of preservative-free tafluprost on keratocytes, sub-Basal nerves, and endothelium: a single-blind one-year confocal study on naïve or treated glaucoma and hypertensive patients versus a control group
Rossi GC; Blini M; Scudeller L; Ricciardelli G; Depolo L; Amisano A; Bossolesi L; Pasinetti GM; Bianchi PE
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 821-825
54746 Poly-(cyclo)dextrins as ethoxzolamide carriers in ophthalmic solutions and in contact lenses
Garcí,a-Ferná,ndez MJ; Tabary N; Martel B; Cazaux F; Oliva A; Taboada P; Concheiro A; Alvarez-Lorenzo C
Carbohydrate polymers 2013; 98: 1343-1352
54757 The prevalence of ocular surface complaints in Brazilian patients with glaucoma or ocular hypertension
Costa VP; Marcon IM; Galvã,o Filho RP; Malta RF
Arquivos Brasileiros de Oftalmologia 2013; 76: 221-225
54861 Signs and symptoms of ocular surface disease in patients on topical intraocular pressure-lowering therapy
Gomes B; Turiel PR; Marques FP; Bernardo FP; Safady MV; Portes AL; Santhiago MR
Arquivos Brasileiros de Oftalmologia 2013; 76: 282-287
54415 Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study
Singh J; Chhabra G; Pathak K
Drug Development and Industrial Pharmacy 2014; 40: 1223-1232
54624 Influence of BAK-preserved prostaglandin analog treatment on the ocular surface health in patients with newly diagnosed primary open-angle glaucoma
Tomić M; Ka&scaron,telan S; Soldo KM; Salopek-Rabatić J
BioMed research international 2013; 2013: 603782
54533 A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate
Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q
International Journal of Pharmaceutics 2013; 455: 75-84
54466 Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma
Kashiwagi K; Ito K; Haniuda H; Ohtsubo S; Takeoka S
Investigative Ophthalmology and Visual Science 2013; 54: 5629-5637
54517 Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study
Nebbioso M; Evangelista M; Librando A; Plateroti AM; Pescosolido N
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2013; 67: 659-663
54793 In vitro characterization of a controlled-release ocular insert for delivery of brimonidine tartrate
Mealy JE; Fedorchak MV; Little SR
Acta biomaterialia 2014; 10: 87-93
54348 Sustained release of matrix metalloproteinase-3 to trabecular meshwork cells using biodegradable PLGA microparticles
Turturro S; Sunoqrot S; Ying H; Hong S; Yue BY
Molecular pharmaceutics 2013; 10: 3023-3032
54785 Physicochemical and Pharmacological Investigation of Topical Ocular w/o Microemulsion of Timolol Maleate for Treatment of Glaucoma
Hegde RR; Bhattacharya SS; Verma A; Ghosh A
Current Eye Research 2014; 39: 155-163
54526 Long acting betaxolol ocular inserts based on polymer composite
Gevariya HB; Patel JK
Current Drug Delivery 2013; 10: 384-393
